Almost one year after filing a New Drug Application for an ADHD drug and less than one year after announcing it secured $200 million in financing, Ironshore Pharmaceuticals closed its doors.
Mr. du Toit is responsible for leading Publicis Health’s global business development strategy.
Novartis hired Elizabeth Barrett, Pfizer’s head of oncology, to replace Bruno Strigini, the chief executive officer of Novartis Oncology who retired at the end of 2017.
McCann Health announced the appointment of Marcus Sigurdsson to the new position of Global Chief Digital Officer.
GlaxoSmithKline Chief Executive Officer Emma Walmsley continues to overhaul the company’s pharmaceutical division. Since assuming GSK’s helm, Walmsley has replaced about 50 of its top managers.
OvaScience is restructuring to cut costs. As part of that process, the company is laying off about half of its staff.
Expansion Therapeutics officially launched with the close of a $55.3 million Series A financing.
Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced the promotion of five employees in its Chicago office.
Privately held Dart NeuroScience and its quest to develop therapies intended to improve cognitive vitality will close its doors on Feb. 9, 2018, due to poor progress on the San Diego-based company’s therapeutic goals and little return on hundreds of millions of dollars in research and development.
Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced several leadership promotions.